Meanti, R., Rizzi, L., Bresciani, E., Licata, M., Molteni, L., Omeljaniuk, R., et al. (2024). Selected Growth Hormone Secretagogues (GHS) as disease modifiers in an in vitro model of Amyotrophic Lateral Sclerosis: a proof-of-concept study. Intervento presentato a: 9th European Congress of Pharmacology (EPHAR 2024), Atene, Grecia.

Selected Growth Hormone Secretagogues (GHS) as disease modifiers in an in vitro model of Amyotrophic Lateral Sclerosis: a proof-of-concept study

Ramona Meanti
Primo
;
Laura Rizzi;Elena Bresciani;Martina Licata;Laura Molteni;Vittorio Locatelli;Antonio Torsello
2024

abstract + poster
Neuroprotection, neuroscience, GHS, ALS
English
9th European Congress of Pharmacology (EPHAR 2024)
2024
2024
open
Meanti, R., Rizzi, L., Bresciani, E., Licata, M., Molteni, L., Omeljaniuk, R., et al. (2024). Selected Growth Hormone Secretagogues (GHS) as disease modifiers in an in vitro model of Amyotrophic Lateral Sclerosis: a proof-of-concept study. Intervento presentato a: 9th European Congress of Pharmacology (EPHAR 2024), Atene, Grecia.
File in questo prodotto:
File Dimensione Formato  
Meanti-2024-EPHAR 2024-AAM.pdf

accesso aperto

Descrizione: Intervento a convegno - abstract
Tipologia di allegato: Author’s Accepted Manuscript, AAM (Post-print)
Licenza: Altro
Dimensione 517.13 kB
Formato Adobe PDF
517.13 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/521863
Citazioni
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
Social impact